Dr. Schorry is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3333 Burnet Ave
# ML4006
Cincinnati, OH 45229Phone+1 513-636-4760Fax+1 513-636-7297
Education & Training
- Cincinnati Children's Hospital Medical CenterResidency, Pediatrics, 1984 - 1985
- Cincinnati Childrens Hospital Medical CenterInternship, Transitional Year, 1982 - 1983
- University of Michigan Medical SchoolClass of 1982
Certifications & Licensure
- OH State Medical License 1985 - 2026
- American Board of Medical Genetics and Genomics Clinical Genetics
- American Board of Pediatrics Pediatrics
Clinical Trials
- A Randomized Placebo-Controlled Study of Lovastatin in Children With Neurofibromatosis Type 1 Start of enrollment: 2009 Jul 01
- Everolimus for Children With NF1 Chemotherapy-Refractory Radiographic Progressive Low Grade Gliomas Start of enrollment: 2010 Jul 10
- Phase 2 Study of Bevacizumab in Children and Young Adults With NF 2 and Progressive Vestibular Schwannomas Start of enrollment: 2013 May 15
- Join now to see all
Publications & Presentations
PubMed
- 102 citationsHealth Supervision for Children With Neurofibromatosis Type 1David T. Miller, Debra Freedenberg, Elizabeth K. Schorry, Nicole J. Ullrich, David Viskochil
Pediatrics. 2019-05-01 - 307 citationsRevised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation.Eric Legius, Ludwine Messiaen, Pierre Wolkenstein, P Pancza, Robert A. Avery
Genetics in Medicine. 2021-05-19 - 100 citationsPediatric plexiform neurofibromas: impact on morbidity and mortality in neurofibromatosis type 1.Carlos E. Prada, Fatima A. Rangwala, Lisa J. Martin, Anne Lovell, Howard M. Saal
The Journal of Pediatrics. 2012-03-01
Journal Articles
- Expanding the Clinical Phenotype of Individuals with a 3-Bp in-Frame Deletion of the NF1 Gene (c.2970_2972del): An Update of Genotype–Phenotype CorrelationRachel K Hachen, Elizabeth K Schorry, Arthur S Aylsworth, Katherine A Rauen, Ashraf Syed, Daryl A Scott, Lois J Starr, Donald G Basel, Lynne M Bird, Leah W Burke, Mari..., Nature
- Copb2 Is Essential for Embryogenesis and Hypomorphic Mutations Cause Human MicrocephalyElizabeth Schorry, Kristen Sund, Cynthia A Prows, Human Molecular Genetics
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: